Rockwell Medical, Inc. (RMTI)
| Market Cap | 35.08M |
| Revenue (ttm) | 101.49M |
| Net Income (ttm) | -782,000 |
| Shares Out | 34.06M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 72,910 |
| Open | 1.040 |
| Previous Close | 1.030 |
| Day's Range | 1.000 - 1.050 |
| 52-Week Range | 0.860 - 5.150 |
| Beta | 1.62 |
| Analysts | Strong Buy |
| Price Target | 4.00 (+288.35%) |
| Earnings Date | May 12, 2025 |
About RMTI
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate mixer, as well as ancillary products, including 5... [Read more]
Financial Performance
In 2024, Rockwell Medical's revenue was $101.49 million, an increase of 21.38% compared to the previous year's $83.61 million. Losses were -$782,000, -90.90% less than in 2023.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for RMTI stock is "Strong Buy." The 12-month stock price forecast is $4.0, which is an increase of 288.35% from the latest price.
News
Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the first quarter ended March 31, 2025 on Monday, May 12, 2025.
Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript
Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Heather Hunter - Senior Vice President, Chief Corporate Affairs Officer Mark Strob...
Rockwell Medical Announces Fourth Quarter and Full-Year 2024 Financial and Operational Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical achieves profitability on an adjusted EBITDA basis for the full-year 2024, the first time in the Company's history.
Rockwell Medical to Exhibit at DialysisTechConneXion42 in Booth# 112
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will showcase its hemodialysis concentrates portfolio at DialysisTechConneXion42 on April 1-4, 2025 in Las Vegas, NV in...
Rockwell Medical Named 'Great Place to Work' for Third Year in a Row
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work for the third year in a row.
Rockwell Medical to Release Fourth Quarter and Full-Year 2024 Results on Thursday, March 20, 2025
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2024 on Thursday, March 20, 2025.
Rockwell Medical Adds Single-Use Bicarbonate Cartridge to Hemodialysis Concentrates Product Portfolio
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical adds a 510k approved single-use bicarbonate cartridge--in two sizes, 720g and 900g--to its hemodialysis concentrates po...
Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is the leading supplier of liquid bicarbonate in the United States.
UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions
Rockwell Medical Promotes Jesse Neri to Chief Financial Officer
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has been instrumental in strengthening Rockwell Medical's financial infrastructure and developing a stronger financial organi...
Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's DAMX45 dry acid concentrate mix system is 510(k) approved to be used exclusively with the Company's dry acid concentr...
Rockwell Medical Expands Distribution in the Philippines
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will be the exclusive supplier of all dry hemodialysis concentrates products to Nephro Group.
Rockwell Medical's Dip Gives A Speculative Opportunity
Despite a 39% stock drop yesterday, Rockwell Medical's strong Q3 results and upcoming catalyst provide a solid buying opportunity for risk-takers. The stock's dip was due to reduced orders from its la...
Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript
Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President & Chief Corporate Affairs Officer Mark S...
Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and nine months ended September 30, 2024.
Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--UPDATED Q3'24 EARNINGS DATE: Rockwell Medical will release its third quarter 2024 financial and operational results on November 12, 2024...
Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the third quarter ended September 30, 2024 on Monday, November 1...
Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production'
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Great Place to Work and Fortune magazine selected Rockwell Medical for the 2024 Fortune Best Workplaces in Manufacturing and Production ...
Rockwell Medical: The Turnaround Is Looking Real
Rockwell develop concentrates for hemodialysis, which is a process that seeks to artificially replace kidney function in patients with chronic failure. Despite being a critical product, there's curren...
Rockwell Medical Announces Product Purchase Agreement with Leading At-Home and Acute Care Dialysis Provider
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces a product purchase agreement with the leading at-home and acute care dialysis provider in the United States.
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
Rockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and six months ended June 30, 2024.
Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Convenience Pack offers a number of advantages for home hemodialysis patients and acute care dialysis facilities.
Rockwell Medical Looks Like A Speculative Buy As It Approaches Profitability
Rockwell is a microcap manufacturer of hemodialysis concentrates for kidney failure patients, trading at under 1x full-year 2023 revenue. The company has a significant market opportunity with the grow...